N+1 Singer appointed as Joint Broker to Miton Group PLC

N+1 Singer is pleased to announce the appointment as ‘Joint Broker’ to Miton Group PLC with immediate effect.  Miton Group PLC manages a range of equity funds investing in many of the largest markets and multi-asset

Read More
The benefits of an IPO and what it means to become a Publicly Listed Company

As recently seen in the latest edition of the North East Times, Rachel Hayes (Corporate Broking Director at N+1 Singer) discussed the intricacies of what it means to go public, and why companies choose to IPO. Rachel

Read More
Thomson Reuters Analyst Awards 2018

We are delighted to announce that the N+1 Singer Life Sciences and Healthcare Team has been ranked ‘Top Earnings Estimator’ in Biotechnology for the Europe region for 2018.  The awards are globally recognised as the gold

Read More
Hipgnosis Songs Fund Ltd Publicly Lists on the Specialist Fund Segment

Today marks the first day of dealings for Hipgnosis Songs Fund Ltd, as they list on the Specialist Fund Segment on the Main Market on the London Stock Exchange.   Founded by Merck Mercuriadis, former manager

Read More
[Video] N+1 Singer’s Emerging Companies Lunch

Last Thursday we held our second ‘Emerging Companies Lunch’ at The NED, in the City of London. Our private company lunches pair up fast-growing private companies with fund managers focused on small cap opportunities. For our

Read More
[Video] Mark Gibbon discusses the N+1 Singer Best Ideas H1 Review

Mark Gibbon, Head of Research at N+1 Singer, discusses the N+1 Singer Best Ideas H1 Review.  For more information, email enquiries@n1singer.com

Read More